We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca is a company with a turbulent history ... It is based on an adenoviral vector based on a weakened version of the adenovirus that causes a common cold-line illness in chimpanzees ...

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

Analyst Sachin Jain from Bank of America Securities maintained a Buy rating on AstraZeneca (AZN – Research Report) and keeping the price target at p14,500.00. Sachin Jain’s rating is based on ...

As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD.

The U.K. pharmaceutical company AstraZeneca has become the largest multinational drugmaker in China, drawing 13% of its $5.8 billion in revenue last year from there, against a backdrop of an acute ...

AstraZeneca (AZN) said Monday at the ObesityWeek conference in San Antonio, Texas that its experimental obesity pill was well-tolerated by patients with type-2 diabetes as it presented data from ...

AstraZeneca disclosed Wednesday that Leon Wang, a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese ...

Immunai Inc., a New York-based artificial intelligence and biotech company specializing in mapping the human immune system, ...

AstraZeneca’s China president is under investigation in mainland China, the drug company said on Wednesday. Leon Wang was described as cooperating “with an ongoing investigation”, the ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-8.40%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...